PGM2L1 and synovial sarcoma: Multiple immunohistochemistry (mIHC) analysis demonstrated that most TOX-, DNM3-, KLHL42-, PGM2L1-, and SESN3-positive cells co-localized with CD4 in SS skin lesions (Fig. S6B).